BIOMERICA, INC.
Income Statement
| Line Item | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.6M | $5.8M | $5.1M | $5.0M | $5.1M | $6.5M | $6.1M | $4.9M |
| Cost of Revenue | $3.8M | $3.8M | $3.6M | $3.4M | $3.5M | $4.0M | $3.8M | $3.4M |
| Gross Profit | $1.8M | $2.0M | $1.5M | $1.5M | $1.7M | $2.4M | $2.3M | $1.5M |
| Gross Margin | 31.5% | 34.9% | 29.7% | 31.1% | 32.6% | 37.5% | 37.8% | 31.1% |
| Operating Expenses | ||||||||
| Research & Development | $1.4M | $1.1M | $780.3K | $733.6K | $589.9K | $459.1K | $347.1K | $420.6K |
| SG&A Expense | $1.8M | $1.8M | $1.6M | $1.5M | $1.5M | $1.5M | $1.4M | $1.2M |
| Operating Income | $-1.5M | $-954.6K | $-827.0K | $-670.6K | $-446.6K | $514.0K | $505.0K | $-132.3K |
| Operating Margin | -26.6% | -16.5% | -16.1% | -13.5% | -8.7% | 7.9% | 8.3% | -2.7% |
| Interest Expense | $37 | $282 | $167 | — | $142 | $302 | $1.6K | $5.8K |
| Pretax Income | $-1.4M | $-908.6K | $-796.0K | $-646.4K | $-426.4K | $524.5K | $613.4K | — |
| Income Tax Expense | $31.8K | — | $703.8K | $-315.0K | $-210.8K | $-12.5K | $65.0K | $2.0K |
| Net Income | $-1.5M | $-908.6K | $-1.5M | $-331.4K | $-215.7K | $537.0K | $548.4K | $157.4K |
| Net Margin | -26.3% | -15.7% | -29.2% | -6.7% | -4.2% | 8.3% | 9.0% | 3.2% |
| EPS (Basic) | $-0.17 | $-0.11 | $-0.20 | $-0.04 | $-0.03 | $0.08 | $0.08 | $0.02 |
| EPS (Diluted) | $-0.17 | $-0.11 | $-0.20 | $-0.04 | $-0.03 | $0.07 | $0.08 | $0.02 |
| Shares Outstanding (Basic) | 8.6M | 8.3M | 7.6M | 7.6M | 7.4M | 7.0M | 6.9M | — |
| Shares Outstanding (Diluted) | 8.6M | 8.3M | 7.6M | 7.6M | 7.4M | 7.5M | 7.1M | 6.7M |
| Dividends Per Share | — | — | — | — | — | — | — | — |